Press Release

IQVIA Selected as a 2022 Shanghai Global Investment Partner

Jul 19, 2022

The 2022 Shanghai Global Investment Promotion Conference was held on Thursday, June 16, 2022.

At this event, the Mayor and Deputy Party Secretary of Shanghai, Zheng Gong, announced that IQVIA is the sole healthcare organization to be selected for Shanghai’s Global Investment Partnership Program in 2022. As a member of the partnership program, IQVIA will contribute to the growth objectives of Shanghai.

The theme for this year’s Shanghai Global Investment Promotion Conference is “New Look, New Momentum, New Future.” Officials and business leaders witnessed the signing of 322 investment projects valued at 566 billion yuan during the Shanghai Global Investment Promotion Conference. The number and value of investments surpassed last year’s records. Shanghai will continue its effort to identify new opportunities for economic growth, accelerate innovation, and strengthen its ecosystem with the new development strategies.

“We are honoured to be a member of the Shanghai Global Investment Partners. IQVIA established its China headquarters in Shanghai in 1994. Over the past 28 years, we witnessed the rapid transformation of Shanghai into a world class city that embraces innovation, cultural diversity, and fair competition. We are excited by the outlook for Shanghai’s economic growth and its business-friendly environment,” said IQVIA Chairman and CEO Ari Bousbib.

IQVIA has built close partnerships with key stakeholders in Shanghai, including the city government, hospitals, higher education institutions, and other international corporations. In 2021, IQVIA established a presence in the Qiantan International Business Zone to support the growing needs across the life sciences industry in this region.

Shanghai has become a leading hub for biomedical research and biopharmaceutical industry. Together with our customers and partners, we look forward to embarking on the journey to advance healthcare and improve patient lives in Shanghai and throughout China.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

Contact Us